Direct comparison
BPC-157 vs TB-500
Class
BPC
Thymosin
Mechanism
BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of a human gastric juice protein.
TB-500 (as a synthetic analog of thymosin beta-4, a naturally occurring peptide) interacts with G-actin and regulates actin polymerisation in cells.
Studied effects
Recovery, Immunomodulation
Recovery, Muscle growth, Immunomodulation
Evidence level
preclinical
preclinical
Legal status (DE)
not approved
not approved
WADA-listed
Yes
Yes
Half-life
Very short: in a preclinical ADME study (rat/dog), the elimination half-life was under 30 minutes (rat, IV ~15 min).
No published human pharmacokinetic data.
Studies cited
3
3
Sourcing & partnersAd
europeptidesPEPTICA
europeptides
Visit partner →unyxpeptides
unyxpeptides
Visit partner →clearpeptidesPeptica
clearpeptides
Visit partner →Partner / affiliate links — Peptica may earn a commission. No endorsement; not medical advice. Peptica sells no substances.
Important notice
This site is intended solely for factual, scientifically oriented information about peptides. It does not constitute medical advice, does not replace a consultation with a doctor and contains no recommendations for use in humans. Peptica sells no substances and names no sources for unapproved substances.